CFTR and cystic fibrosis: Our study focused on the determination of the ion transporter targets, and we showed that E2 decreased ASL height in non-CF cells through the inhibition of cAMP mediated Cl− secretion, indicating CFTR as the target of E2, which is consistent with previous studies showing the inhibition of this Cl− channel after exposure to E2 [14].